Boston Scientific Corporation Price Today
Boston Scientific Corporation
BSX
Healthcare
$72.92B
💰
Market Cap
86.0
💸
Price to Earnings
$0.6
🎉
EPS
+74
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
19 |
Strong Buy |
13 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
BSX Price Forecast Target
50.7 👉 68.0 +34%
BSX EPS Forecast
0.6 👉 2.2 +280%
Financials
Profit Margin
7 %
Revenue Growth
10.9 %
Dividend
$ 0
Held Percent
0.3% - Insiders
94.2% - Institutions
5.5% - Public
Major Fund Holders
-
💰 Blackrock Inc. $7.0B
-
💰 Vanguard Group Inc $6.1B
-
💰 FMR, LLC $5.8B
-
💰 Massachusetts Financial Services Co. $4.0B
-
💰 State Street Corporation $3.1B
Stock Ideas
Carl Icahn Portfolio
With a staggering net worth exceeding $16 billion, Icahn has made a lasting impact on the stock market as the founder and manager of Icahn Enterprises. Known as a 'corporate raider,' Icahn has gained fame for his relentless pursuit of undervalued co…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …📮FAQ
Some Frequently Asked Questions.
The Boston Scientific Corporation industry is Medical Devices
The Boston Scientific Corporation sector is Healthcare
The Boston Scientific Corporation forecasted predicted Price to Earnings PE ratio is 22.6
The Boston Scientific Corporation Price to Earnings PE ratio is 86.0
The Market Capitalization of Boston Scientific Corporation is $72.92B
There are total of 1460079511 float shares with 94.2% held by Institutions and 0.3% held by insiders
The MBoston Scientific Corporation forecasted Earnings per Share EPS is $2.2
The Boston Scientific Corporation Earnings per Share EPS is 0.6
The Boston Scientific Corporation company has $8679000000 gross profits with 7 profit margins
The Boston Scientific Corporation Earnings Growth is 0.059% with 0.038% quarterly earnings growth
The Boston Scientific Corporation Revenue is $13400000512 with 0.109 revenue growth
The price target for Boston Scientific Corporation stock is $68.0 for the high target and $55.0 for the low target
The consensus analyst recommendations for Boston Scientific Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Boston Scientific Corporation is Buy, with the following breakdown:
- Buy: 19
- Strong Buy: 13
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of Boston Scientific Corporation is 0.8
The dividend of Boston Scientific Corporation is $0
The dividend yield of Boston Scientific Corporation is 0%
The biggest institutional and mutual fund holders of Boston Scientific Corporation stock are
- Blackrock Inc.
- Vanguard Group Inc
- FMR, LLC
- Massachusetts Financial Services Co.
The Boston Scientific Corporation ESG Score is 74, with the following breakdown:
- E: 3.0
- S: 12.69
- G: 10.63